MedTrace Logo

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab

NCT02665689 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-11-20

Study results available
· View outcomes & findings →

Summary

The aim of the prospective randomized study is to investigate whether a intensified diabetic control program leads to better final visual acuity and less frequent diabetic ocular complications in patients with diabetic retinopathy when compared with a normal diabetic treatment.

Conditions

  • Visual Acuity Reduced Transiently
  • Macular Edema, Cystoid

Interventions

DRUG

ranibizumab

Ranibizumab injections will be given for diabetic macular edema. In the experimental arm insulin injections and antihypertensiva will be applied.

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Prof. Dr. Antonia M. Joussen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-18
Primary Completion
2018-09-07
Completion
2018-09-07

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665689 on ClinicalTrials.gov